Safer deprescribing, clearer decisions.
DeRxAI is a clinical decision support tool that helps pharmacists and primary care clinicians spot medication risk, surface tapering and review guidance, and reduce polypharmacy in older adults — grounded in published, openly licensed evidence and built for real clinical workflow.
One clear read on a patient's medication list
DeRxAI turns a complex medication list into a structured, referenced review — so a deprescribing conversation takes minutes, not an afternoon.
Medication risk review
Flags anticholinergic burden, delirium risk, and polypharmacy at a glance.
Deprescribing guidance
Shows the published tapering and monitoring guidance that applies, with the source named — not just "stop this drug."
Frailty & renal aware
Factors in eGFR and Clinical Frailty Scale, so guidance fits the whole patient.
Audit-ready summaries
Exports a clear, referenced summary for the chart in seconds.
Not another static checklist.
Most deprescribing tools are PDFs and flowcharts. DeRxAI is built on structured clinical rules that reason about the whole patient — and it's designed by a pharmacist, not just engineered around one.
Meet the team & our approach →Rules you can trace
Every suggestion links back to a defined rule and a named reference — never a black box.
Built for Ontario, first
Ontario review, documentation and funding context that most generic tools skip entirely.
Clinician stays in charge
DeRxAI supports the decision. It doesn't make it for you.
Get notified when DeRxAI launches
Join clinicians across Ontario shaping the tool as we build it. No spam — just launch updates and early access.
By signing up you agree to receive occasional product updates. Unsubscribe anytime. See our Terms & Disclaimer.